Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
Korean J Radiol. 2022 Jun;23(6):615-624. doi: 10.3348/kjr.2021.0786. Epub 2022 Mar 8.
To compare the therapeutic outcomes of laparoscopic hepatic resection (LHR) and laparoscopic radiofrequency ablation (LRFA) for single subcapsular hepatocellular carcinoma (HCC).
We screened 244 consecutive patients who had received either LHR or LRFA between January 2014 and December 2016. The feasibility of LRFA in patients who underwent LHR was retrospectively assessed by two interventional radiologists. Finally, 60 LRFA-feasible patients who had received LHR and 29 patients who had received LRFA as the first treatment for a solitary subcapsular HCC between 1 cm and 3 cm were finally included. We compared the therapeutic outcomes, including local tumor progression (LTP), recurrence-free survival (RFS), and overall survival (OS) between the two groups before and after propensity score (PS) matching. Multivariable Cox proportional hazard regression was also used to evaluate the difference in OS and RFS between the two groups for all 89 patients.
PS matching yielded 23 patients in each group. The cumulative LTP and OS rates were not significantly different between the LHR and LRFA groups after PS matching ( = 0.900 and 0.003, respectively). The 5-year LTP rates were 4.6% and 4.4%, respectively, and OS rates were 100% and 90.7%, respectively. The RFS rate was higher in LHR group without statistical significance ( = 0.070), with 5-year rates of 78.3% and 45.3%, respectively. OS was not significantly different between the LHR (reference) and LRFA groups in multivariable analyses, with a hazard ratio (HR) of 1.33 (95% confidence interval, 0.12-1.54) ( = 0.818). RFS was higher in LHR (reference) than in LRFA without statistical significance in multivariable analysis, with an HR of 2.01 (0.87-4.66) ( = 0.102).
There was no significant difference in therapeutic outcomes between LHR and LRFA for single subcapsular HCCs measuring 1-3 cm. The difference in RFS should be further evaluated in a larger study.
比较腹腔镜肝切除术(LHR)与腹腔镜射频消融术(LRFA)治疗单发包膜下肝细胞癌(HCC)的疗效。
我们筛选了 2014 年 1 月至 2016 年 12 月期间接受 LHR 或 LRFA 的 244 例连续患者。两位介入放射科医生回顾性评估了 LHR 后行 LRFA 的可行性。最终,纳入了 60 例可行 LRFA 的 LHR 后患者和 29 例 1-3cm 单发包膜下 HCC 行 LRFA 作为首次治疗的患者。我们比较了两组患者的治疗结果,包括局部肿瘤进展(LTP)、无复发生存率(RFS)和总体生存率(OS),并在倾向评分(PS)匹配前后进行了比较。多变量 Cox 比例风险回归也用于评估两组患者的 OS 和 RFS 差异。
PS 匹配后每组各有 23 例患者。PS 匹配后,LHR 和 LRFA 组的累积 LTP 和 OS 率无显著差异(=0.900 和 0.003)。5 年 LTP 率分别为 4.6%和 4.4%,OS 率分别为 100%和 90.7%。RFS 率在 LHR 组较高,但无统计学意义(=0.070),5 年率分别为 78.3%和 45.3%。多变量分析中,LHR(参照)与 LRFA 组的 OS 无显著差异,风险比(HR)为 1.33(95%置信区间,0.12-1.54)(=0.818)。RFS 在 LHR(参照)组较高,但多变量分析无统计学意义,HR 为 2.01(0.87-4.66)(=0.102)。
对于 1-3cm 的单发包膜下 HCC,LHR 和 LRFA 的治疗结果无显著差异。RFS 的差异需要在更大的研究中进一步评估。